About Us
To achieve our goals in the field of healthcare, we work together with representatives of large pharmacy chains and medical structures from different countries.
Present time
SPEY is an international pharmaceutical company founded in 2001Our company is engaged in the development and marketing of high-quality and innovative pharmaceutical products for the needs of a wide range of therapeutic areas. All products are manufactured at production facilities equipped with advanced technology and approved by the world quality standards of the World Health Organization (WHO) and Good Manufacturing Practice (GMP).
In a short period of time, SPEY has become one of the most dynamically developing global pharmaceutical companies, with business connections in more than 20 countries around the world. Among them: Russia, Armenia, Azerbaijan, Georgia, CIS countries (Kazakhstan, Tajikistan, Uzbekistan, Turkmenistan and Kyrgyzstan), India, Nepal, Mongolia, Southeast Asian countries (Philippines, Vietnam, Cambodia, Myanmar) and markets in Africa and Latin America.
In today's society, SPEY strives to improve the quality of life of people with effective and affordable medicines. We are sure that successful projects are born from good ideas and their high-quality execution together with great talent.
Company in numbers
Medications
Such a number of our products are produced annually on the production lines of our partners, and this figure continues to grow.
Employees
Our main asset is our close-knit team of medical representatives, distributors and marketing and sales specialists.
Items
We have already produced more than 300 well-established registered names of drugs on the market.
Branches
The company's work around the world is supported by 15 of our branches-representative offices, which allows us to ensure uninterrupted supply of the necessary volumes of medicines.
Countries of presence
Large regular deliveries of SPEY products are carried out in 5 regions of the world, such as Europe, Africa, Latin America, Southeast Asia and Central Asia.
-
Our mission
To contribute to improving the health and well-being of people.
-
Our vision
To be a leading company, recognized for quality and innovation.
Our values
Life
We recognize life as a gift that needs to be cherished.
Creation
We are discovering new facets of the possible.
Responsibility
We are responsible for the well-being of society.
Team spirit
We are united and achieve our goals.
Professionalism
We show a high level of working skills.
Relationship
We value everyone's opinion.
Research, development and production areas
In the pharmaceutical industry, it is always important to move forward - this is what the employees of our research centers in different countries are doing.
Specialists in the creation of new dosage forms have modern equipment and high-precision analytical devices at their disposal. SPEY already has many achievements in the pharmaceutical industry, and drug development continues.
Today, the company is developing more than 30 new drugs in various dosage forms.
The creative approach is based on the work of scientists and excellent equipment of laboratories - this is how we create new products and move the entire healthcare industry forward. All types of research are available to us, from research in the field of analytical chemistry to the evaluation of the final product on focus groups of patients.
We pay great attention to the issue of the production of drugs and choose the most modern production sites, which are located in several European countries, proven by time and quality control system. All of them work together with research centers and are equipped according to the standards of the World Health Organization and Good Manufacturing Practice.
These production sites are serviced by qualified employees - they are responsible for the production of really effective dosage forms. The production sites of our partners are constantly being improved, modern technological processes are being introduced on them. Quality audits are also regularly conducted, in which representatives of partner companies from different countries and state regulatory authorities take part.